Bal Pharma Ltd.
| BSE: 524824 | Sector: Health care |
| NSE: BALPHARMA | ISIN Code: INE083D01012 |
| BSE 00:00 | 16 Apr | 62.40 |
0.15 (0.24%) |
OPEN
63.10 |
HIGH
64.00 |
LOW
61.00 |
| NSE 00:00 | 16 Apr | 62.55 |
-0.10 (-0.16%) |
OPEN
63.50 |
HIGH
64.25 |
LOW
62.15 |
| OPEN | 63.10 |
| PREVIOUS CLOSE | 62.25 |
| VOLUME | 3174 |
| 52-Week high | 73.00 |
| 52-Week low | 33.50 |
| P/E | 160.00 |
| Mkt Cap.(Rs cr) | 92 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Bal Pharma Ltd. (BALPHARMA) - Cash Flow
| Figures in Rs crore | 2020 | 2019 | 2018 |
| Opening Cash & Cash Equivalents | 2.20 | 2.58 | 2.07 |
| Net Cash From Operating Activities | 21.57 | 11.55 | 12.57 |
| Net Cash Used In/from Investing Activities | -3.16 | -11.98 | -15.59 |
| Net Cash Used In/from Financing Activities | -19.94 | 0.05 | 3.53 |
| Net (decrease)/increase In Cash and Cash Equivalents |
-1.52 | -0.38 | 0.51 |
| Closing Cash & Cash Equivalents | 0.68 | 2.20 | 2.58 |
Quick Links for Bal Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
